Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.57 USD | +3.81% | +6.33% | +56.47% |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
Mar. 28 | Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target | MT |
- Stock Market
- Equities
- MRUS Stock
- News Merus N.V.